Form 8-K - Current report:
SEC Accession No. 0001654954-24-014547
Filing Date
2024-11-15
Accepted
2024-11-15 16:06:25
Documents
16
Period of Report
2024-11-15
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K endra_8k.htm   iXBRL 8-K 24187
2 PRESS RELEASE endra_ex991.htm EX-99.1 122553
  Complete submission text file 0001654954-24-014547.txt   281558

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA endra-20241115.xsd EX-101.SCH 5882
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE endra-20241115_lab.xml EX-101.LAB 14667
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE endra-20241115_cal.xml EX-101.CAL 901
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE endra-20241115_pre.xml EX-101.PRE 9278
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE endra-20241115_def.xml EX-101.DEF 2102
18 EXTRACTED XBRL INSTANCE DOCUMENT endra_8k_htm.xml XML 3904
Mailing Address 3600 GREEN COURT SUITE 350 ANN ARBOR MI 48105
Business Address 3600 GREEN COURT SUITE 350 ANN ARBOR MI 48105 734-335-0468
ENDRA Life Sciences Inc. (Filer) CIK: 0001681682 (see all company filings)

EIN.: 260579295 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37969 | Film No.: 241467865
SIC: 3845 Electromedical & Electrotherapeutic Apparatus
(CF Office: 08 Industrial Applications and Services)